Dr. Rina Rosenzweig completed her BA in Molecular Biochemistry cum laude at the Technion-Israel Institute of Technology in 2003. She completed the direct PhD program there in 2010, and conducted her postdoctoral research at the University of Toronto. There, she used cutting-edge NMR techniques developed in the lab to study molecular mechanisms involved in guiding protein refolding and disaggregation. She joined the Department of Structural Biology in June 2016.
Dr. Rosenzweig uses nuclear magnetic resonance (NMR) to understand molecular mechanisms that can rescue our cells from the accumulation of misfolded and aggregated proteins associated with protein misfolding and degenerative diseases. These include Parkinson’s, Huntington’s, and Alzheimer's diseases, amyotrophic lateral sclerosis (ALS), and Creutzfeldt-Jakob disease. Understanding the molecular mechanisms involved in reversing protein aggregation could therefore be a vital step in preventing, slowing down, or ultimately, even reversing the progression of these diseases.
Her academic and professional honors include The Joseph Freed and Benjamin Werber Fellowship in 2006, an Irwin and Joan Jacobs Scholarship and a fellowship of excellence from the Department of Biology at the Technion in 2009. In 2010, Dr. Rosenzweig was awarded a National Postdoctoral Award for Women in Science by the Weizmann Institute. She won an EMBO long-term fellowship in 2010 and 2011, a Banting Postdoctoral Fellowship from 2012 to 2014, the Lap-Chee Tsui CIHR Publication Award in 2013, and the Azreili Foundation Faculty Fellowship in 2016.